Washington therapist reveals how she was told to ‘throw out all her training’ and give ‘gender affirming care’ to abused, autistic, suicidal 13-YEAR-OLD

A Washington therapist has revealed how she was told to ‘throw out’ all of her medical training and give ‘gender affirming care’ to an abused, autistic, and suicidal 13-year-old.  

Tamara Pietzke, 36, quit the profession after she was reprimanded by her superiors for not immediately signing off on children’s requests for puberty blockers and sex change surgeries. 

Some of the kids who wanted to be transgender had a multitude of issues – including physical and mental abuse, raging anxiety, depression, and suicidal thoughts. 

Despite this, she was shunned into quickly signing papers to give them life-changing medication – and when she brought up her concerns, she was accused of being prejudiced against trans kids, reports The Free Press.  

Mom-of-three Pietzke decided to become a therapist in her 20s, and she graduated from the University of Washington with a master’s in social work in 2012. 

Pietzke has worked with hundreds of clients in Puget Sound, Washington, over the last decade – but she quit her job in January because she was told to ‘throw out’ her training if a young person had gender dysphoria.

Instead of assessing them properly, she was told to just approve their medical transition. 

Writing in The Free Press, the therapist revealed: ‘I was getting the message from my supervisors that when a young person I was seeing expressed discomfort with their gender—the diagnostic term is gender dysphoria—I should throw out all my training.

‘No matter the patient’s history or other mental health conditions that could be complicating the situation, I was simply to affirm that the patient was transgender, and even approve the start of a medical transition.’ 

Keep reading

Canada halts controversial assisted suicide program for mentally ill due to lack of doctors willing to participate

Canada has delayed the extension of its assisted suicide program to people suffering solely from mental illness, health officials announced Monday. 

Canada offers medically assisted death to terminally and chronically ill people, but the plan to extend the program to people with mental illnesses has divided Canadians, the New York Times reported.

Some critics attribute the problem to a lack of adequate psychiatric care in the country.

The controversial policy would allow anyone in Canada with an incurable medical condition to apply for assisted suicide, even if the disease is not terminal, which makes the law one of the most liberal assisted suicide programs in the world. 

Canada introduced medically assisted dying after its Supreme Court ruled in 2015 that requiring people to cope with intolerable suffering infringed on fundamental rights to liberty and security.

The law was expanded in 2021 to include people experiencing “grievous and irremediable” conditions, such as depression and other mental health issues. 

Over 13,000 Canadians were euthanized as part of the program in 2022, the Daily Mail reported

When the program was announced last year, one conservative lawmaker “charged that the Liberal government of Prime Minister Justin Trudeau is promoting a ‘culture of death.’”

Keep reading

New Hawaii Bill Would Create A Limited Therapeutic Psilocybin Program To Treat Certain Mental Health Conditions

Newly introduced legislation in Hawaii would create explicit legal protections around the therapeutic use of psilocybin, with eligible patients able to possess and consume the psychedelic under a trained facilitator’s care.

The measure is the result of a task force on breakthrough therapies that was formed last year to explore the issue, its sponsor, Sen. Chris Lee (D), told Marijuana Moment.

SB 3019 would not legalize psilocybin itself but would instead create an affirmative defense for qualified patients and their caregivers, effectively exempting them from state laws against psilocybin. A companion bill in the House, HB 2630, is sponsored by Rep. Della Au Belatti (D) and 13 others.

“There’s a lot of use cases where these kinds of things can really help improve quality of life, and significantly, at minimal cost compared to other kinds of alternative treatment,” Lee said of psychedelics like psilocybin and MDMA, both of which have been designated by the federal Food and Drug Administration (FDA) as breakthrough therapies.

In Hawaii in particular, he noted, there are large numbers of veterans with post-traumatic stress disorder (PTSD) and other behavioral health ailments, as well as older people seeking end-of-life care—groups that might benefit from facilitated psilocybin use.

Under the new legislation, mental health professionals would need to identify a person as having at least one of several listed eligible medical conditions, then write a recommendation for therapeutic psilocybin. Patients would be allowed no more than five grams of psilocybin per session and would need to complete a preparation session prior to the drug being administered.

Eligible conditions for treatment with psilocybin would include post-traumatic stress disorder (PTSD); treatment-resistant depression or major depressive disorder; end-of-life anxiety, existential stress and demoralization; eating disorders such as anorexia and bulimia, substance use disorders and obsessive compulsive disorder (OCD). Additional qualifying conditions could be added by the state Department of Health in response to requests from patients or mental health professionals.

Keep reading

I spent over £100,000 on therapy… but it was taking magic mushrooms that helped me conquer my OCD

On the surface, Pandora Morris, 35, has everything. She’s pretty, blonde, well-connected and has a posh London address – the type of woman you might see on the pages of society magazine Tatler.

But there is a sadness about her cornflower blue eyes which reflect a less golden story. Pandora, a lawyer by profession and scion of a large London banking dynasty, has spent decades battling obsessive compulsive disorder (OCD), which developed into a severe exercise addiction and eating disorder in her early teens.

It has been more than three years since her last ‘relapse’, and though wary of describing herself as ‘cured’, Pandora is now in a very different place to her condition before lockdown, when her heart rate fell to 31 and doctors told her that if she didn’t stop exercising eight hours a day and eat more than 700 calories, she would probably die.

When we meet, Pandora has just come from the studio where she is recording the second series of Hurt To Healing, the podcast she launched in October 2022, in which she interviews experts and those who have struggled with mental health issues.

Pandora certainly knows her subject. Her desperate parents spent the price of a small house on treatments — none of which, including seven months in an eating disorder clinic in South Africa, seemed to work long term.

Keep reading

Teen tourists stabbed by deranged stranger at Grand Central who shouted ‘I want all the white people dead’ on Christmas: police

A troubled vagrant randomly stabbed two teenage girls enjoying a Christmas morning meal with their parents at a Grand Central Terminal restaurant — after ranting that he wanted “all white people dead,” authorities said.

The girls, 14- and 16-year-olds visiting from South America, were attacked at Tartinery in the Grand Central Dining Concourse around 11:25 a.m. Monday and suffered non-life-threatening stab wounds, police and sources said. 

“I want all the white people dead,” the suspect, Steven Hutcherson, 36, allegedly yelled, according to police sources. “I want to sit next to the crackers.”

He then allegedly lunged at the unsuspecting teens, plunging a knife into the 16-year-old’s back, nicking her lungs, and stabbing the younger girl in the thigh, police and a law enforcement source said.

Hutcherson — who cops and sources said has a slew of prior arrests and a history of mental health issues — had allegedly popped up at the restaurant and said he wanted a table but wasn’t going to order anything, staffers told The Post.

Keep reading

Psilocybin’s ‘Efficacy And Safety’ For Bipolar II Depression Demonstrated By American Medical Association Study

Results of a new clinical trial published by the American Medical Association “suggest efficacy and safety” of psilocybin-assisted psychotherapy for treatment of bipolar II disorder, a mental health condition often associated with debilitating and difficult-to-treat depressive episodes.

“The 15 participants in this trial had well-documented treatment-resistant BDII depression of marked severity and a lengthy duration of the current depressive episode,” authors wrote. After seven psychotherapy sessions, one involving a single dose of psilocybin, the paper says, study subjects “displayed strong and persistent antidepressant effects, with no signal of worsening mood instability or increased suicidality.”

In the nonrandomized controlled study, which was conducted at Sheppard Pratt Hospital in Baltimore, “12 patients met both response and remission criteria” at the end of a 12-week study period, the trial found, meaning that measures of the diagnosis had dropped by more than half and fell below a minimum threshold.

“The findings in this open-label nonrandomized controlled trial suggest efficacy and safety of psilocybin with psychotherapy in BDII depression.”

Patients’ self-reported quality of life scores “demonstrated similar improvements,” the study, which was funded by the biotechnology company COMPASS Pathways that develops psychedelic treatments, found. In terms of safety, metrics of suicidal ideation and mania “did not change significantly at posttreatment compared to baseline.”

The nine-author study, published on Wednesday in the journal JAMA Psychiatry, involved administering a single, 25-milligram dose of psilocybin. Patients with bipolar II disorder (BDII) met with therapists seven times—during three pre-treatment sessions, once during an “8-hour dosing day” and at three post-treatment integration sessions.

“In this study, most participants remitted rapidly (ie, within 1 week of dosing), and in most participants, remission persisted for the 12-week study duration,” the report says. “The 3 participants who restarted medication due to lack of benefit or relapse following improvement generally had poorer response throughout the trial.”

“In a sample of patients with treatment-resistant cyclical mood disorder, achieving persistent remission over a 3-month period is notable, especially given the single dosing of psilocybin,” it continues. “Further follow-up is warranted.”

Keep reading

Transgender Man Charged for Alleged Threats to Kill, Rape Children

A man who identifies as female has been indicted on 14 felony counts after reportedly threatening to rape girls in public restrooms over “transphobia,” as well as commit a school shooting and kill children “on behalf” of the transgender community.

Alexia Willie, previously named Jason Lee Willie, was arrested on August 14 in Perry County, Illinois, after the FBI intercepted a livestream on social media, in which the trans individual was making a number of threats, according to multiple reports.

“A person in Tennessee walked into one of your schools and shot up a bunch of your Christian daughters. That’s not the last of them if you don’t shut your fucking mouth. Shut the fuck up out here, you understand me?” Willie said, according to court records filed on November 7.

“There’s a lot of transgenders out here that are tired of being picked on and we’re going to go into the schools and we’re going to kill their fucking children out here, and that’s the end of it. We’re at war,” Willie added.

Police also reportedly said that Willie was inspired by the transgender school shooting at the Covenant School in Nashville, Tennessee, earlier this year, which left six people dead.

“I’m in the bathroom feeling your little girls’ pussies. I love feeling on your little girls’ pussies,” Willie continued in the livestream. “You can’t do nothing about it. I don’t care. I’m openly a pedophile. You guys can’t do nothing about us. You can cry. Put me on national television, I don’t care.”

Keep reading

Blaming Mass Shootings on Mental Illness Doesn’t Address Either Issue

Since a gunman went on a rampage in Lewistown, Maine, killing 16 people, we’ve learned a few things about the shooter, Robert Card, who was found with a fatal self-inflicted gunshot wound after a two-day manhunt. A member of the Army Reserve, Card had recently been committed to a mental health facility after he reported hearing voices and threatened to shoot up the National Guard base in Saco, Maine.

Card’s mental health history has been central to reporting that laid out the lead-up to the deadliest mass shooting in the US this year. Questions of how Card was able to have access to guns, given his psychiatric hospitalization and documented concerns of family and soldiers in his reserve unit, drove much of the coverage. Lax gun laws that allow people like Card to slip through the cracks warrant interrogation, but the reality is that most mass shooters don’t have a mental health history like Card’s, nor is a record of mental illness a good predictor of gun violence.

Card’s ability to carry out this tragedy is a symptom of the gun violence crisis in the US, but the presence of his mental illness is not representative of the issue. In the vast majority of cases of mass violence, mental illness is not considered a primary factor. Attempting to rationalize the horrors of a mass shooting by emphasizing the perpetrator’s mental state does very little to address the larger issue at best, and leads to dangerous mental health stigma at worst.

Keep reading

Cannibal Released From Connecticut Psych Ward Early For ‘Good Behavior’ Even Though He Told Psychiatrist He Wanted to Eat Her Flesh

Tyree Smith, a brain-eating cannibal was released from a Bridgeport, Connecticut psych ward 50 years earlier than his scheduled release date for ‘good behavior’ even though he previously told his psychiatrist he wanted to eat her flesh.

“Tyree Smith is an individual with a psychiatric illness requiring care, custody and treatment,” the board stated in its report this week. “Since his last hearing Tyree Smith has continued to demonstrate clinical stability. Mr. Smith is medication compliant, actively engaged in all recommended forms of treatment, and has been symptom-free for many years.”

Smith, who was 36 at the time, was sentenced to 60 years in a psych ward in September 2013 (effectively a life sentence) after a jury found him not guilty of murder by way of insanity.

In December 2011, Smith murdered a homeless man, Angel Gonzalez, mutilated his body and ate his brains and eyeballs.

A psychiatrist previously testified that Smith said he heard voices that told him to eat Gonzalez’s brains and eyes ‘to better understand human behavior’ and ‘to gain vision into the spiritual real.’. He also expressed his desire to consume her flesh.

Tyree Smith was released from the psych ward this week after the state board determined he has been ‘symptom-free’ for many years.

“He denied experiencing cravings but stated that if they were to arise, he would reach out to his hospital and community supports and providers,” the report stated, according to the CT Post.

Keep reading

Study: Cannabis Exposure Not Associated with Increased Psychosis Risk Among High-Risk Youth

The use of cannabis doesn’t raise one’s risk of psychosis or other adverse health outcomes, even among adolescents who are at high risk for the disorder, according to longitudinal data published in the journal Psychiatry Research.

A team of researchers affiliated with Hofstra University in New York and with Stanford University in California assessed the relationship between cannabis use and health outcomes in a cohort of adolescents at clinical high risk for psychosis. Study participants were tracked for two years. 

Investigators reported that those subjects who consumed cannabis were no more likely than non-users to become psychotic. 

Authors concluded: [C]ontinuous cannabis use over 2-years of follow-up was not associated with an increased psychosis transition rate, and did not worsen clinical symptoms, functioning levels, or overall neurocognition …  indicating that CHR [clinical high risk] youngsters are not negatively impacted by cannabis. … These findings should be confirmed in future clinical trials with larger samples of cannabis using individuals.”

The findings are similar to those published in April in the journal Psychiatry and Clinical Neurosciences. That study also failed to identify cannabis use as a risk factor for psychosis in clinically at-risk subjects. The study’s authors concluded: “Our primary hypothesis was that cannabis use in CHR [clinically high risk] subjects would be associated with an increased rate of later transition to psychosis. However, there was no significant association with any measure of cannabis use. … These findings are not consistent with epidemiological data linking cannabis use to an increased risk of developing psychosis.” 

Keep reading